| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 2,415 | 4,420 | 2,828 | 970 |
| Research and development | 28,938 | 40,517 | 50,811 | 50,723 |
| General and administrative | 13,238 | 15,910 | 17,598 | 16,760 |
| Restructuring costs | 479 | 32,609 | - | - |
| Total operating expenses | 42,655 | 89,036 | 68,409 | 67,483 |
| Loss from operations | -40,240 | -84,616 | -65,581 | -66,513 |
| Interest income | 3,351 | 3,794 | 4,348 | 6,743 |
| Other expense, net | -23 | -143 | -140 | -66 |
| Total other income, net | 3,328 | 3,651 | 4,208 | 6,677 |
| Loss before income taxes | -36,912 | -80,965 | -61,373 | -59,836 |
| Provision for (benefit from) income taxes | -371 | 44,802 | -1,178 | -835 |
| Net income (loss) | -36,541 | -125,767 | -60,195 | -59,001 |
| Basic (in dollars per share) | -0.68 | -2.34 | -1.12 | -1.1 |
| Diluted (in dollars per share) | -0.68 | -2.34 | -1.12 | -1.1 |
| Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) | 53,830,000 | 53,827,000 | 53,827,000 | 53,790,000 |
| Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) | 53,830,000 | 53,827,000 | 53,827,000 | 53,790,000 |
PROTHENA CORP PUBLIC LTD CO (PRTA)
PROTHENA CORP PUBLIC LTD CO (PRTA)